← brief for 2026-10-25 · Slowing decline

Evaluating the role of metabolic surgery versus GLP1 agonists in patients living with obesity and chronic kidney disease - a systematic review.

Article A Peer reviewed Meta-analysis or large trial

Key takeaways

This review looked at 6 studies comparing weight loss surgery and GLP-1 drugs. It found that both options can protect the kidneys in people with obesity and diabetes. This is a high-level summary of existing evidence.

Who did this work

Davey MG · Heneghan HM · Corcelles R

Source

Article · PubMed, CKD progression and prevention · 2026 Oct 25
https://pubmed.ncbi.nlm.nih.gov/42928025/